switching between glp-1 agonists 📚There’s a growing trend you’re seeing for a reason: some patients are from medications to dual agonists., This isn’t about hype. It’s about physiology., 🧠GLP-1 like Semaglutide GLP-1 Receptor Agonists Explained for
Description
Psychiatric safety of semaglutide for weight management in people without known major psychopathology: post hoc analysis of the STEP 1, 2, 3, and 5 trials

Some patients, termed super-responders, lose more weight than expected
Some patients may feel tempted to wait for retatrutide because headlines sound impressive

Nonexpression of GLP-1R is common in advanced pancreatic tumors with lymphatic metastasis and is associated with poor prognosis, suggesting that GLP-1R may inhibit tumorigenesis and metastasis of human pancreatic cancer cells both in vitro and in vivo

RANKL: receptor activator of nuclear factor kappa B ligand

[29] Pratt, E., Ma, X., Liu, R., Robins, D., Haupt, A., Coskun, T.,
